EuroQol sponsors ISPOR Europe 2024 symposium on using HRQoL data from children and youth to strengthen HTA: What are the challenges? How can we improve current practice?
Attending ISPOR Europe 2024 in Barcelona this month? Interested in...
Four-year EuroQol initiative to help accelerate COVID-19 related research ends
Over the duration of the COVID-19 pandemic emergency, the EuroQol...
Our Monthly Scientific Selection: October Publications on EuroQol Instruments #10
[1-31 October 2024] Stalmeier PFM, Roudijk B. What Makes the...
August 16, 2022
Study team co-investigators updated
The research team for the UK EQ-5D-5L valuation study has been updated. The lead investigator is Donna Rowen (School of Health and Related Research, University of Sheffield) and co-investigators are:
- Nathan Bray (Centre for Health Economics and Medicines Evaluation, Bangor University)
- Jill Carlton (School of Health and Related Research, University of Sheffield)
- Louise Longworth (PHMR, London)
- David Meads (Academic Unit of Health Economics, Leeds Institute for Health Sciences, University of Leeds)
- Clara Mukuria (School of Health and Related Research, University of Sheffield)
- Ciaran O’Neill (Centre for Public Health, Queens University Belfast)
- Yaling Yang (Nuffield Department of Primary Care Health Sciences, University of Oxford)
This team has been carefully selected by the project’s Steering Group and will bring significant experience and expertise to the valuation study.